JP2002523184A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523184A5
JP2002523184A5 JP2000567167A JP2000567167A JP2002523184A5 JP 2002523184 A5 JP2002523184 A5 JP 2002523184A5 JP 2000567167 A JP2000567167 A JP 2000567167A JP 2000567167 A JP2000567167 A JP 2000567167A JP 2002523184 A5 JP2002523184 A5 JP 2002523184A5
Authority
JP
Japan
Prior art keywords
corresponds
quality
rubber material
package according
material consists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000567167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523184A (ja
Filing date
Publication date
Priority claimed from SE9802938A external-priority patent/SE9802938D0/xx
Application filed filed Critical
Publication of JP2002523184A publication Critical patent/JP2002523184A/ja
Publication of JP2002523184A5 publication Critical patent/JP2002523184A5/ja
Pending legal-status Critical Current

Links

JP2000567167A 1998-09-01 1999-08-24 注射溶液のための改良された安定性 Pending JP2002523184A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802938A SE9802938D0 (sv) 1998-09-01 1998-09-01 Improved stability for injection solutions
SE9802938-2 1998-09-01
PCT/SE1999/001440 WO2000012043A1 (en) 1998-09-01 1999-08-24 Improved stability for injection solutions

Publications (2)

Publication Number Publication Date
JP2002523184A JP2002523184A (ja) 2002-07-30
JP2002523184A5 true JP2002523184A5 (https=) 2006-10-05

Family

ID=20412436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000567167A Pending JP2002523184A (ja) 1998-09-01 1999-08-24 注射溶液のための改良された安定性

Country Status (33)

Country Link
US (4) US6576245B1 (https=)
EP (1) EP1109526B1 (https=)
JP (1) JP2002523184A (https=)
KR (1) KR100614162B1 (https=)
CN (1) CN1230141C (https=)
AR (1) AR033788A1 (https=)
AT (1) ATE262882T1 (https=)
AU (1) AU754447C (https=)
BR (1) BR9913261A (https=)
CA (1) CA2340238C (https=)
CZ (1) CZ2001743A3 (https=)
DE (1) DE69916082T2 (https=)
DK (1) DK1109526T3 (https=)
EE (1) EE04768B1 (https=)
ES (1) ES2217808T3 (https=)
HU (1) HUP0104161A3 (https=)
ID (1) ID28015A (https=)
IL (2) IL141333A0 (https=)
IS (1) IS2230B (https=)
MY (1) MY120822A (https=)
NO (1) NO322292B1 (https=)
NZ (1) NZ509985A (https=)
PL (1) PL195244B1 (https=)
PT (1) PT1109526E (https=)
RU (1) RU2224499C2 (https=)
SA (1) SA99200573B1 (https=)
SE (1) SE9802938D0 (https=)
SK (1) SK285474B6 (https=)
TR (1) TR200100679T2 (https=)
TW (1) TWI228987B (https=)
UA (1) UA73282C2 (https=)
WO (1) WO2000012043A1 (https=)
ZA (1) ZA200101590B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US6802828B2 (en) * 2001-11-23 2004-10-12 Duoject Medical Systems, Inc. System for filling and assembling pharmaceutical delivery devices
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
EP1594434B1 (en) * 2003-01-14 2016-09-07 Yeda Research and Development Co. Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
KR100505557B1 (ko) * 2003-02-10 2005-08-03 조을룡 약병마개 제조용 고무 조성물
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
CN103957966B (zh) * 2011-09-27 2017-09-29 贝克顿迪金森法国公司 等离子体处理过的硅油作为医用注射装置中的涂层的用途
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381779A (en) 1981-07-16 1983-05-03 Sterling Drug Inc. Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
DE69000716T2 (de) 1989-03-28 1993-07-22 Duphar Int Res Vorgefuellte injektionsvorrichtung mit einem fass, das mit einer fluessigen diazepam-formulierung gefuellt ist.
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
SE9501472D0 (sv) 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions

Similar Documents

Publication Publication Date Title
JP2002523184A5 (https=)
JP2002532112A5 (https=)
BR9917641B1 (pt) artigos absorventes com costuras laterais refixáveis.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
AU2001244618A1 (en) Substituted 1,3-thiazole compounds, their production and use
ZA200201494B (en) Benzodiazepin derivatives, the production and use thereof.
JP2003520017A5 (https=)
JP2001010627A5 (https=)
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
IT1318319B1 (it) Composizione di gomma, procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma.
ITRM20000067A0 (it) Autoveicolo aperto.
JP2003213455A5 (https=)
JP2006511228A5 (https=)
BR0003689B1 (pt) composiÇço de borracha contendo duas sÍlicas.
JP2002509169A5 (https=)
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
JP2000279802A5 (https=)
MA26860A1 (fr) Pyrroles substitues.
JP2004315602A5 (https=)
ITPD20020134A1 (it) Cassonetto ribaltabile, particolarmente per veicoli speciali multifunzione o simili.
NL1015302A1 (nl) Werkwijze voor de productie van 2,3-dimethylbuteen-1 en 2,3-dimethylbuteen-2.
ITRM20000091V0 (it) Contenitore per fard, ombretto, rimmel o simili.
ES1051774Y (es) Bolsa con percha.
IT1307822B1 (it) Procedimento per la realizzazione di materiali multiuso.